0001862900-26-000011.txt : 20260708 0001862900-26-000011.hdr.sgml : 20260708 20260708163023 ACCESSION NUMBER: 0001862900-26-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260706 FILED AS OF DATE: 20260708 DATE AS OF CHANGE: 20260708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Porter James Richard CENTRAL INDEX KEY: 0001862900 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40671 FILM NUMBER: 261162702 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvalent, Inc. CENTRAL INDEX KEY: 0001861560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 508-446-2272 MAIL ADDRESS: STREET 1: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 ownership.xml 4 X0609 4 2026-07-06 0001861560 Nuvalent, Inc. NUVL 0001862900 Porter James Richard false C/O NUVALENT, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 true true false false President and CEO true Class A Common Stock 2026-07-06 4 M false 30000 18.93 A 354879 D Class A Common Stock 2026-07-06 4 S false 30000 123.72 D 324879 D Stock Option (Right to Buy) 18.93 2026-07-06 4 M false 30000 0.00 D 2032-01-04 Class A Common Stock 30000 118686 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.66 to $123.78, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price. The shares underlying this option are fully vested. /s/ Nathan McConarty, attorney-in-fact 2026-07-08